Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. V. von Lueder · SciRah

Researcher profile · Semantic Scholar

T. V. von Lueder

Share profile

T. V. von Lueder — researcher profile on SciRah

h-index: 21
Works: 44
Citations: 2,760

Most-cited papers

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
J. Cleland, K. Bunting, M. Flather, D. Altman +17 more
2018European Heart Journal582 citations Open access
Semantic Scholar
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
D. Kotecha, J. Holmes, H. Krum, D. Altman +12 more
2014The Lancet468 citations Open access
Semantic Scholar
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy
T. V. von Lueder, Bing H. Wang, A. Kompa, Li Huang +4 more
2015Circulation: Heart Failure283 citations Open access
Semantic Scholar
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.
D. Kotecha, M. Flather, D. Altman, J. Holmes +14 more
2017Journal of the American College of Cardiology242 citations Open access
Semantic Scholar
Renin-Angiotensin Blockade Combined With Natriuretic Peptide System Augmentation: Novel Therapeutic Concepts to Combat Heart Failure
T. V. von Lueder, S. Sangaralingham, Bing H. Wang, A. Kompa +3 more
2013Circulation: Heart Failure141 citations Open access
Semantic Scholar
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
D. Kotecha, L. Manzano, H. Krum, G. Rosano +17 more
2016British medical journal120 citations Open access
Semantic Scholar
Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury.
M. S. Ahmed, J. Gravning, V. Martinov, T. V. von Lueder +7 more
2011American Journal of Physiology. Heart and Circulatory Physiology92 citations
Semantic Scholar
RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials
T. V. von Lueder, H. Krum
2013Cardiovascular Drugs and Therapy91 citations
Semantic Scholar
Current role of neprilysin inhibitors in hypertension and heart failure.
T. V. von Lueder, D. Atar, H. Krum
2014Pharmacology and Therapeutics75 citations
Semantic Scholar
Medical Therapies for Heart Failure With Preserved Ejection Fraction.
S. Kjeldsen, T. V. von Lueder, O. Smiseth, K. Wachtell +8 more
2019HYPERTENSION71 citations Open access
Semantic Scholar
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.
D. Kotecha, S. Gill, M. Flather, J. Holmes +18 more
2019Journal of the American College of Cardiology65 citations Open access
Semantic Scholar
Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction.
A. Kompa, Jia-Yu Lu, Thomas J Weller, D. Kelly +3 more
2018International Journal of Cardiology53 citations
Semantic Scholar
Neurohormonal Blockade in Heart Failure.
T. V. von Lueder, D. Kotecha, D. Atar, I. Hopper
2016Cardiac failure review52 citations Open access
Semantic Scholar
New medical therapies for heart failure
T. V. von Lueder, H. Krum
2015Nature Reviews Cardiology51 citations
Semantic Scholar
Comorbidities in Heart Failure: Are There Gender Differences?
I. Hopper, D. Kotecha, K. Chin, R. Mentz +1 more
2016Current Heart Failure Reports49 citations Open access
Semantic Scholar
CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
J. Gravning, M. Ahmed, T. V. von Lueder, T. Edvardsen +1 more
2013International Journal of Cardiology46 citations
Semantic Scholar
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
K. Chin, R. Ofori-Asenso, I. Hopper, T. V. von Lueder +4 more
2018Cardiovascular Research45 citations Open access
Semantic Scholar
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.
T. S. Hall, T. V. von Lueder, F. Zannad, P. Rossignol +6 more
2018International Journal of Cardiology41 citations
Semantic Scholar
Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1.
T. V. von Lueder, H. Kjekshus, T. Edvardsen, E. Øie +5 more
2004Cardiovascular Research36 citations Open access
Semantic Scholar
Cardiac-restricted Expression of the Carboxyl-terminal Fragment of GRK3 Uncovers Distinct Functions of GRK3 in Regulation of Cardiac Contractility and Growth
L. Vinge, T. V. von Lueder, E. Aasum, E. Qvigstad +13 more
2008Journal of Biological Chemistry35 citations Open access
Semantic Scholar
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.
Bing H. Wang, T. V. von Lueder, A. Kompa, Li Huang +4 more
2015International Journal of Cardiology31 citations
Semantic Scholar
Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling.
M. Ahmed, E. Øie, L. Vinge, T. V. von Lueder +2 more
2007Cardiovascular Research21 citations
Semantic Scholar
Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload.
T. V. von Lueder, J. Gravning, O. How, L. Vinge +7 more
2012American Journal of Physiology. Heart and Circulatory Physiology16 citations
Semantic Scholar
Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels.
T. V. von Lueder, M. Melsom, D. Atar, S. Agewall
2011Clinical Laboratory13 citations
Semantic Scholar
Advances in Heart Failure Management
H. Krum, T. V. von Lueder
201212 citations
Semantic Scholar
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System.
T. V. von Lueder, D. Atar, S. Agewall, J. K. Jensen +5 more
2019American Journal of Therapeutics8 citations Open access
Semantic Scholar
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction.
T. S. Hall, T. V. von Lueder, F. Zannad, P. Rossignol +7 more
2019American Heart Journal8 citations Open access
Semantic Scholar
Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis
D. Kotecha, M. Flather, D. Altman, J. Holmes +15 more
20173 citations
Semantic Scholar
Erythropoiesis-stimulating agents to reduce heart failure hospitalization: a systematic review and meta-analysis.
K. Bunting, Otilia Țica, A. Champsi, Madeleine Perrett +4 more
2026European Journal of Heart Failure2 citations Open access
Semantic Scholar
Cardiac Dimensions and Function are Not Altered among Females with the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
P. O. Iversen, T. V. von Lueder, K. R. Kardel, Katarina Lien
2020Healthcare2 citations Open access
Semantic Scholar
Impact of Renal Impairment on Beta-Blocker Ef ﬁ cacy in Patients With Heart Failure
D. Kotecha, S. Gill, M. Flather, J. Holmes +18 more
20202 citations
Semantic Scholar
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy.
S. Kjeldsen, D. Atar, T. V. von Lueder
2019European Heart Journal - Cardiovascular Pharmacotherapy2 citations
Semantic Scholar
In memoriam Henry Krum, 1958-2015
T. V. von Lueder, I. Hopper, D. Kotecha, D. Atar
2016The Cardiology1 citations
Semantic Scholar
PT357 Angiotensin-receptor neprilysin-inhibition (ARNi) attenuates ischemic cardiac failure in vivo and angiotensin-II-induced cellular cardiac hypertrophy and fibrosis
T. V. von Lueder, Bing H. Wang, A. Kompa, R. Webb +2 more
20141 citations
Semantic Scholar
The Angiotensin-Receptor Neprilysin Inhibitor LCZ 696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy
von Lueder, T. V. von Lueder, Bing H. Wang, A. Kompa +5 more
20141 citations
Semantic Scholar
Angiotensin Receptor Neprilysin Inhibition (ARNi) Attenuates Adverse Cardiac Remodelling In Vitro and In Vivo
T. V. von Lueder, Bing Wang, A. Kompa, L. Huang +4 more
20131 citations Open access
Semantic Scholar
Etiology and overview of heart failure
H. Krum, T. V. von Lueder, Y. Wong, G. Felker
20121 citations
Semantic Scholar
Molecular Mechanisms of Cardiac Hypertrophy and Heart Failure
T. V. von Lueder
20111 citations
Semantic Scholar
University of Birmingham Impact of renal impairment on beta-blocker efficacy in patients with heart failure
S. Gill, M. Flather, J. Holmes, M. Packer +14 more
20200 citations
Semantic Scholar
Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction
D. Kotecha, L. Manzano, H. Krum, G. Rosano +16 more
20160 citations
Semantic Scholar
Abstract 13368: Angiotensin-Receptor Neprilysin-Inhibitor Reduces Adverse Cardiac Remodeling after Experimental Myocardial Infarction by Direct Effect on Cardiac Hypertrophy and Fibrosis
T. V. von Lueder, Bing H. Wang, A. Kompa, R. Webb +3 more
20130 citations
Semantic Scholar
ADDITION OF NEPROLYSIN INHIBITOR, LBQ-657 TO ANGIOTENSIN RECEPTOR BLOCKER, VALSARTAN PROVIDES SUPERIOR ANTI-FIBROTIC AND ANTI-HYPERTROPHIC EFFECTS IN VITRO
Bing H. Wang, T. V. von Lueder, Li Huang, A. Kompa +3 more
20120 citations Open access
Semantic Scholar
Impact of Renal Impairment on Beta-Blocker Ef ﬁ cacy in Patients With Heart Failure
D. Kotecha, S. Gill, M. Flather, J. Holmes +18 more
0 citations
Semantic Scholar
University of Groningen Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure Beta-Blockers Heart Failure
D. Kotecha, S. Gill, M. Flather, J. Holmes +14 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Krum×16
Invite
H. Krum — researcher profile on SciRah
D. Kotecha×15
Invite
D. Kotecha — researcher profile on SciRah
D. Atar×13
Invite
D. Atar — researcher profile on SciRah
D. van Veldhuisen×11
Invite
D. van Veldhuisen — researcher profile on SciRah

×10

Invite

J. Wikstrand — researcher profile on SciRah

Invite

J. Holmes — researcher profile on SciRah

Invite

A. Coats — researcher profile on SciRah

Invite

L. Manzano — researcher profile on SciRah

Invite

G. Rosano — researcher profile on SciRah

Invite

A. Kompa — researcher profile on SciRah

Invite

M. Flather — researcher profile on SciRah

Invite

M. Böhm — researcher profile on SciRah